August 2025 in “American Journal of Clinical Dermatology” Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.
6 citations
,
January 2021 in “Journal of The American Academy of Dermatology” Scalp photography helps patients feel less anxious about hair loss, agree more with doctors on severity, and stay motivated for treatment.
December 2024 in “Qlantic Journal of Social Sciences and Humanities” Men seeking hair transplants show higher perfectionism and body dysmorphic disorder symptoms.
1 citations
,
May 2022 in “Голова и шея.” Patients with traumatic brain injury need comprehensive care to improve their well-being.
46 citations
,
August 2019 in “Journal of the European Academy of Dermatology and Venereology” People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.
29 citations
,
December 2022 in “Dermatology and Therapy” Emotional symptoms from alopecia areata reduce work productivity and daily activity.
February 2025 in “Clinical Cosmetic and Investigational Dermatology” Genetic risk for hair loss can increase depression risk, but depression doesn't increase hair loss risk.
July 2023 in “Media Dermato Venereologica Indonesiana” Accurate diagnosis of RDEB-mitis in older adults is crucial for proper management without immunosuppressants.
Androgenetic alopecia in young males leads to lower self-esteem, increased anxiety, and higher depression risk.
3 citations
,
January 2019 in “Xin li xue jin zhan” July 2024 in “Journal of Investigative Dermatology” Pediatric patients with dystrophic epidermolysis bullosa face more hospital admissions, procedures, and complications than others.
November 2022 in “Journal of Investigative Dermatology” COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.
February 2026 in “Journal of Cosmetic Dermatology” A new reliable scale improves accuracy in measuring hair density and treatment response.
63 citations
,
March 1998 in “Archives of Dermatology” Antidepressants may improve or resolve scalp dysesthesia in most patients.
January 2024 in “Wiadomości Lekarskie” New methods are improving treatment for depression.
September 2022 in “Journal of Investigative Dermatology” Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.
16 citations
,
February 2017 in “Dermatology and Therapy” The new visual scale is a quick and effective way to measure hair loss in women.
February 2026 in “Skin Appendage Disorders” Pseudofolliculitis barbae is linked to higher rates of anxiety and depression.
November 2024 in “IP Indian Journal of Clinical and Experimental Dermatology” Alopecia areata greatly affects quality of life, needing psychological support.
2 citations
,
March 2016 in “The Journal of Dermatology” The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.
8 citations
,
October 2021 in “The international journal of risk and safety in medicine” The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.
November 2024 in “Skin Appendage Disorders” Telogen effluvium most affects quality of life in alopecia patients.
6 citations
,
December 2021 in “Journal of Clinical Medicine” LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.
April 2021 in “Reactions Weekly” Finasteride increases risk of depression, possibly suicidal thoughts, and sexual dysfunction.
August 2018 in “Journal of The American Academy of Dermatology” People with telogen effluvium and scalp discomfort might have low vitamin B12 and could benefit from B12 supplements.
21 citations
,
February 2024 in “JAMA Dermatology” Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.
August 2008 in “European Neuropsychopharmacology” August 2025 in “Brazilian Journal of Hair Health” Hair-related body dysmorphic disorder is common in hair loss patients and needs early recognition for proper treatment.
68 citations
,
March 2019 in “Journal of Cranio-Maxillofacial Surgery” The facial aging scale is a reliable tool for assessing skin aging and treatment effects.
January 2026 in “Psychoneuroendocrinology” Self-collected hair samples can measure stress but may need adjustments for accuracy.